Among the 101 recipients with BK viremia, 12 experienced a subsequent switch from MMF to mTOR inhibitors after the diagnosis of BK viremia, although for 11 of these 12 recipients the change in immunosuppressive therapy occurred because of the concomitant development of BKV-associated nephropathy (data not shown). The gene discussed is MTOR; the disease is Nephropathy.